
Solgar Vitamin K2 MK-7 100mcg Tablets
Best price now
Prices are checked against each store and labelled with when.
Finding cheaper alternatives
Price facts
- Lowest price today: $29.39 at Pakuranga Pharmacy (checked Nov 20, 2026).

Prices are checked against each store and labelled with when.
Solgar Vitamin K2 MK-7 is a daily vitamin K2 supplement built on menaquinone-7, the long-chain form of K2 that occurs naturally in fermented soy foods like natto. Each vegetable capsule supplies 115 mcg of MK-7 plus 100 mg of calcium, and the formula is free of gluten, wheat, yeast, sugar, salt and artificial additives. It suits adults who want a single-capsule K2 supplement from an established brand, especially those pairing K2 with calcium or vitamin D for bone support. Against gummies and sprays, it is a plain capsule with no flavoring or sugar, but it contains milk and soy, which some rival MK-7 products avoid.
In stockShips from New Zealand · priced in NZD (NZ$53.40) · duties may applyReturn policy
Solgar Vitamin K2 MK-7 is a dietary supplement that supplies vitamin K2 as menaquinone-7, an active form of vitamin K. Vitamin K2 supports bone health. It is not readily found in the diet; the body makes it in the gut, and it also occurs in natto, a fermented soybean food, as MK-7.
The product contains milk and soy and is free of gluten, wheat, yeast, sugar, salt, artificial flavors, artificial sweeteners, artificial preservatives and artificial colors. Store at room temperature.
Consult a healthcare practitioner before taking this supplement if you are pregnant, nursing, taking any medications or have any medical condition. All forms of vitamin K may interact with blood-thinning medications, so consult a practitioner first if you take such medicines. Discontinue use and consult a practitioner if any adverse reactions occur, keep the bottle out of reach of children, and do not use it if the outer bottle seal is missing or damaged.
It checks today's price at every store, compares the alternatives and answers in about a minute.







